Chikungunya Epidemic Surges: Two Dead, Thousands Infected; Vaccination Urgent on Reunion Island
Chikungunya outbreak in Réunion Claims Lives,Prompts Vaccination Efforts
Table of Contents
- Chikungunya outbreak in Réunion Claims Lives,Prompts Vaccination Efforts
- chikungunya in Réunion: Your Essential Q&A Guide
- What is Chikungunya?
- Is There a Chikungunya Outbreak in Réunion?
- How Serious is the Current Chikungunya Outbreak?
- Who is at Risk?
- What are the Symptoms of chikungunya?
- Is There a vaccine for Chikungunya?
- What Measures Are Being Taken to Combat the Outbreak?
- How Does the Current Outbreak Compare to Previous Outbreaks?
Published: March 21,2025
SAINT-DENIS,Réunion — An outbreak of Chikungunya on teh French island of Réunion has resulted in two deaths,marking the first confirmed fatalities since the epidemic began in August 2024. Local authorities are mobilizing to combat the spread of the virus, which is transmitted by tiger mosquitoes.
The Regional Health Agency confirmed the deaths of two individuals, ages 86 and 96, who had pre-existing health conditions.
Health officials report a rapid increase in infections across the island.more than 8,500 local cases have been linked to mosquito bites. While the number of infections is significant, the health system has not been overwhelmed, with only 24 patients requiring hospitalization since August 2024.
The current outbreak is less severe than the 2005-2006 epidemic, which affected approximately a third of the island’s population (260,000 people) and resulted in 225 deaths.
Vaccination Campaign Underway
To prevent a large-scale health crisis, the French government has requested intervention from health authorities. In early March, recommendations were made to prioritize vaccination for individuals over 65, those with chronic illnesses such as diabetes, hypertension, or heart disease, and frontline workers.
The french government is prioritizing vaccination for vulnerable populations, including those over 65 and individuals with chronic conditions.
The Chikungunya vaccine, IXCHIQ, produced by Valneva, a Franco-Austrian company, was approved for use in europe in June 2024 and is intended for adults.
The outbreak originated in the southern village of Tampon and has since spread throughout the island. Réunion had been free of Chikungunya cases since 2010.
Chikungunya typically causes fever, severe muscle and joint pain. In some instances, neurological, cardiovascular, or muscular complications can occur, with symptoms lasting for several months, according to news reports.
The world Health Association (WHO) emphasizes that prevention relies on mosquito control measures, including eliminating breeding sites and using insect repellent.
chikungunya in Réunion: Your Essential Q&A Guide
The French island of Réunion is currently experiencing a chikungunya outbreak. This article provides clear answers to the most common questions about the outbreak, its impact, and the steps being taken to address it.
What is Chikungunya?
chikungunya is a viral disease transmitted to humans by infected mosquitoes. it is indeed characterized by:
Fever
Severe muscle and joint pain
In certain specific cases, complications such as neurological, cardiovascular, or muscular issues can occur, wiht symptoms perhaps lasting for several months.
Is There a Chikungunya Outbreak in Réunion?
Yes, Réunion is currently experiencing an outbreak of chikungunya. The outbreak began in August 2024.
The outbreak originated in the southern village of Tampon and has since spread throughout the island.
How Serious is the Current Chikungunya Outbreak?
While health officials report a rapid increase in infections across the island, the current outbreak is less severe than the 2005-2006 epidemic.As of March 2025,there have been two fatalities. Local authorities are working to combat the spread.
The 2005-2006 epidemic affected approximately a third of the island’s population (260,000 people) and resulted in 225 deaths.
The current outbreak has seen over 8,500 local cases linked to mosquito bites.
Who is at Risk?
Anyone living in or traveling to Réunion is potentially at risk of contracting chikungunya. Certain populations are considered more vulnerable:
individuals over 65 years old
Those with chronic illnesses such as diabetes, hypertension, or heart disease
Frontline workers
What are the Symptoms of chikungunya?
The primary symptoms of chikungunya include:
Fever
Severe muscle and joint pain
Is There a vaccine for Chikungunya?
Yes, a vaccine is available.
The Chikungunya vaccine, IXCHIQ, produced by Valneva, was approved for use in Europe in June 2024 and is intended for adults.
Vaccination campaigns have been initiated, with priority given to vulnerable populations.
What Measures Are Being Taken to Combat the Outbreak?
The following measures are being taken:
Vaccination: Prioritizing vaccination for vulnerable populations, including those over 65 and individuals with chronic conditions.
Mosquito Control: The World Health Organization (WHO) emphasizes that prevention relies on mosquito control measures, including eliminating breeding sites and using insect repellent.
How Does the Current Outbreak Compare to Previous Outbreaks?
| Feature | Current Outbreak (August 2024 – March 2025) | 2005-2006 Outbreak |
| —————– | —————————————— | ——————————- |
| Deaths | 2 | 225 |
| Population Affected| Important, over 8,500 cases | Approximately 260,000 |
| Severity | Less severe | More Severe |